Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences IncfiledCriticalEvelo Biosciences Inc
Publication of AR112531A1publicationCriticalpatent/AR112531A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Métodos y composiciones relacionados con la cepa A de Blautia útiles como agentes terapéuticos.Blautia strain A related methods and compositions useful as therapeutic agents.
ARP1801024492017-08-292018-08-29
CANCER TREATMENT USING A BLAUTIA STRAIN
AR112531A1
(en)
"Substituted spirocycle derived compounds, atx inhibitors; pharmaceutical composition comprising them; and its use in the treatment of cancer, inflammations, neuropathic pain, fibrotic diseases, thrombosis, among others ”. pct